EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Production of Respirable Effervescent Microparticles to Enhance Drug Penetration Through Lung Mucus

Valentina Ruggiero, Francesca Mariano, Domenico Larobina, Gaetano D'Avino iD, Marco Trofa iD, Giovanni Falcone iD, Pasquale Del Gaudio iD, Paola Russo iD

Pharmaceutics · 09.07.2026 · 18 (7) · 837

DOI: 10.3390/pharmaceutics18070837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.07.2026. Verfasst von Valentina Ruggiero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca, Ministry of Universities and Research, National Recovery and Resilience Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Dry powder inhalation (DPI) is a promising strategy for the treatment of respiratory diseases such as cystic fibrosis (CF), where thick and viscous mucus limits drug penetration and contributes to persistent infection and inflammation. Although inhalation allows rapid drug action with reduced systemic exposure, its efficacy depends on the ability of inhaled drugs to achieve and maintain therapeutic concentrations in the lungs and to overcome airway barriers. This study aimed to develop and characterize effervescent dry powder formulations designed to enhance mucus permeabilization through mechanical disruption while delivering an antibiotic.

Methods

Effervescent microparticles containing sodium bicarbonate, an organic acid (citric or tartaric acid), and levofloxacin were produced by spray drying using a triple-fluid nozzle to control component distribution and prevent premature effervescence. The influence of functional excipients, including L-leucine and mannitol, on particle formation, aerosol performance, and process yield was evaluated. Microparticles were characterized in terms of morphology, fine particle fraction (FPF), and effervescence-related properties.

Results

Formulations containing L-leucine and citric acid reduced particle agglomeration and achieved a fine particle fraction of up to approximately 18%, although with a lower process yield. In contrast, formulations based on tartaric acid and mannitol improved both production yield and aerosol performance, with FPF values increasing up to 27.3% and more efficient CO2 release. The resulting microparticles exhibited spherical, hollow, and partially fragmented morphology, consistent with premature CO2 generation during spray drying.

Conclusions

The effervescent approach, combined with controlled spray drying parameters, represents a promising formulation strategy to modulate particle behavior and drug release in mucus-relevant environments. These findings support further investigation of effervescent DPI systems for improved pulmonary drug delivery in CF.

Schlagwörter

Stichwörter der Autor:innen

effervescenceinhalable microparticlesmucus barrierparticle engineeringpulmonary drug deliveryspray dryingtriple-fluid nozzle

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.
  • Institute of Polymers, Composites and Biomaterials, National Research Council of Italy, P.le E. Fermi, 1, 80055 Portici, Italy.
  • Dipartimento di Ingegneria Chimica, dei Materiali e della Produzione Industriale, Università degli Studi di Napoli Federico II, P. le Tecchio 80, 80125 Naples, Italy.

ORCID-Profile: Gaetano D'Avino, Marco Trofa, Giovanni Falcone, Pasquale Del Gaudio, Paola Russo

Förderung

  • Ministero dell'università e della ricerca
  • Ministry of Universities and Research
  • National Recovery and Resilience Plan

Zitieren

APA

Ruggiero, V., Mariano, F., Larobina, D., D'Avino, G., Trofa, M., Falcone, G., Del Gaudio, P., & Russo, P. (2026). Design and Production of Respirable Effervescent Microparticles to Enhance Drug Penetration Through Lung Mucus. Pharmaceutics, 18(7), 837. https://doi.org/10.3390/pharmaceutics18070837

Vancouver

Ruggiero V, Mariano F, Larobina D, D'Avino G, Trofa M, Falcone G, et al. Design and Production of Respirable Effervescent Microparticles to Enhance Drug Penetration Through Lung Mucus. Pharmaceutics. 2026;18(7):837. doi:10.3390/pharmaceutics18070837

BibTeX
@article{Ruggiero2026,
  author = {Ruggiero, Valentina and Mariano, Francesca and Larobina, Domenico and D'Avino, Gaetano and Trofa, Marco and Falcone, Giovanni and Del Gaudio, Pasquale and Russo, Paola},
  title = {Design and Production of Respirable Effervescent Microparticles to Enhance Drug Penetration Through Lung Mucus},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {837},
  doi = {10.3390/pharmaceutics18070837}
}
Kostenlos starten →